Sellas Life Sciences Group Inc's Company Valuation
Currency: USD Updated: 2026-07-31
Previous score
9.31
Change
0
The current valuation score of Sellas Life Sciences Group Inc is 9.31, ranking 20 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -43.74, which is -99.14% below the recent high of -0.38 and -54.35% above the recent low of -67.52.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.